Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Amalgamation transactions should be finished after this ..
View:
Post by Mole101 on Jun 06, 2021 5:10pm

Amalgamation transactions should be finished after this ..

ilson, Alain
5 - Senior Officer of Issuer
Holder: The Elegen Group Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$182,672 
+41,296vol 
$4.42 each
54,193  
2021-06-0613:26
 
2021-06-02
$ATE Vaughan, David James
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$77,636 
+17,551 vol
$4.42 each
26,662  
2021-06-0613:22
 
2021-06-02
$ATE Flower, Roderick John
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$306,889 
+69,377vol 
$4.42 each
119,135  
2021-06-0613:18
 
2021-06-02
$ATE Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$1,460,188
+330,098vol 
$4.42 each
442,729  
2021-06-0613:16
 
2021-06-02
$ATE Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$6,620,347
+1,496,631vol 
$4.42 each
1,860,776  
2021-06-0613:11
 
2021-06-02
$ATE Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$205,506 
+46,458vol 
$4.42 each
126,100  
2021-06-0613:09
 
2021-06-02
$ATE Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$2,637,909
+596,340vol 
$4.42 each
830,796  
2021-06-0613:02
 
2021-06-03
$ATE Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-300,300 
-75,000 vol
$4.00 each
755,796  
2021-06-0612:55
 
2021-06-03
$ATE Macnee, Walter Minnes
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-400,300 
-100,000vol 
$4.00 each
385,027
Comment by Forestview on Jun 06, 2021 5:54pm
You're right Mole.  Market cap is now $203.98M (was about $187M on Friday at market close).  Divided by the share price on Friday, leaves about 51.3M shares outstanding - which now accounts for 5.9M shares from Holdings.  Looks like amalgamation is now fully behind us.  Now let's close some deals!
Comment by Doccole on Jun 06, 2021 6:43pm
I assumed there was selling from insiders.  The Canadian volume was high... Insider selling tells me there is nothing on the horizon, or why would insider sell? Am I wrong? Please tell me I am?!
Comment by MrMugsy on Jun 06, 2021 6:53pm
Doccole ... tell me if I'm wrong ... I think we're talking about Dan's sale of $300K in shares and his acquisition of $2,500,000 in shares.  So Dan's buying a used Lambo and McNeece is getting into a Tesla.  : )
Comment by CalgaryATE on Jun 06, 2021 7:10pm
Could it be as simple as selling to save enough to pay the taxman? I know they went with a three cornered amalgamation to reduce their taxes, but they probably still owe some. I imagine it wouldn't be fun trying to pay their taxes next April if they were in the middle of a lock up period (negotiating a buyout/partnership, middle of phase 3).
Comment by Pragmatist on Jun 06, 2021 7:19pm
As long as they received nothing but Antibe shares as "consideration" for the amalgamation, they can defer capital capital gains on the Holdings shares.
Comment by Pragmatist on Jun 06, 2021 7:42pm
Calgary...Pls disregard my last comment.  I see now you were referring to the initial share transfer which occured a few months back.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities